Birken AG files Oleogel S 10 ointment for Wound Treatment at EMA
Birken AG, a biopharmaceutical and dermo-cosmetic company has announced that the European Medicines Agency (EMA) has accepted its Oleogel-S10 Marketing Authorization Application (MAA) for review. Birken�s MAA seeks approval of Oleogel-S10 ointment for accelerated healing of partial thickness Wounds.
Oleogel-S10 is an innovative, sterile ointment which consists only of the active pharmaceutical ingredient �dry extract from birch bark� and sunflower oil. In this unique and internationally patent protected formulation the active pharmaceutical ingredient also functions as sole galenic substance. This formulation of only two ingredients minimizes the risk of wound healing irritations caused by additives.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins